SAI LIFE SCIENCES
|
SAI LIFE SCIENCES Last 5 Year Financial Ratios History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 8.16 | 46.88 | 1.75 | 3.55 | 34.29 |
| CEPS(Rs) | 14.81 | 11.45 | 6.21 | 5.49 | 7.90 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 101.88 | 545.86 | 498.34 | 495.25 | 480.39 |
| Tax Rate(%) | 25.28 | 24.19 | 39.12 | 35.78 | 25.41 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 24.04 | 19.57 | 13.88 | 14.36 | 22.02 |
| EBIT Margin(%) | 18.04 | 13.41 | 8.00 | 7.23 | 15.14 |
| Pre Tax Margin(%) | 13.42 | 7.44 | 1.35 | 1.11 | 10.78 |
| PAT Margin (%) | 10.03 | 5.64 | 0.82 | 0.72 | 8.04 |
| Cash Profit Margin (%) | 18.20 | 13.78 | 8.99 | 11.08 | 18.51 |
| Performance Ratios | |||||
| ROA(%) | 6.17 | 3.69 | 0.46 | 0.31 | 3.79 |
| ROE(%) | 11.02 | 8.99 | 1.14 | 0.72 | 7.43 |
| ROCE(%) | 15.53 | 12.03 | 6.06 | 4.02 | 8.86 |
| Asset Turnover(x) | 0.61 | 0.65 | 0.56 | 0.44 | 0.47 |
| Sales/Fixed Asset(x) | 0.89 | 0.95 | 0.91 | 0.82 | 0.91 |
| Working Capital/Sales(x) | 2.20 | 7.15 | 5.93 | 3.77 | 3.71 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.12 | 1.06 | 1.10 | 1.22 | 1.10 |
| Receivable days | 65.73 | 67.19 | 79.01 | 94.14 | 114.17 |
| Inventory Days | 22.19 | 28.23 | 39.95 | 42.65 | 28.91 |
| Payable days | 180.62 | 142.25 | 176.27 | 230.68 | 234.44 |
| Valuation Parameters | |||||
| PER(x) | 93.36 | - | - | - | - |
| PCE(x) | 51.45 | - | - | - | - |
| Price/Book(x) | 7.48 | - | - | - | - |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 9.18 | 0.39 | 0.52 | 0.73 | 0.76 |
| EV/Core EBITDA(x) | 34.97 | 1.80 | 3.20 | 4.18 | 2.97 |
| EV/EBIT(x) | 50.80 | 2.89 | 6.48 | 10.16 | 5.02 |
| EV/CE(x) | 6.89 | 0.34 | 0.40 | 0.39 | 0.39 |
| M Cap / Sales | 9.37 | - | - | - | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | 15.66 | 20.38 | 39.97 | 14.44 | 4.74 |
| Core EBITDA Growth(%) | 40.60 | 60.63 | 28.64 | -21.37 | 4.93 |
| EBIT Growth(%) | 55.52 | 101.98 | 54.96 | -45.35 | -12.03 |
| PAT Growth(%) | 105.45 | 729.00 | 60.44 | -89.81 | -19.95 |
| EPS Growth(%) | -82.59 | 2,574.70 | -50.57 | -89.66 | -26.39 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.06 | 0.74 | 0.80 | 0.86 | 0.74 |
| Current Ratio(x) | 2.02 | 1.28 | 1.27 | 1.32 | 1.34 |
| Quick Ratio(x) | 1.86 | 1.16 | 1.09 | 1.15 | 1.21 |
| Interest Cover(x) | 3.91 | 2.25 | 1.20 | 1.18 | 3.47 |
| Total Debt/Mcap(x) | 0.01 | - | - | - | - |
Compare Financial Ratios of peers of SAI LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAI LIFE SCIENCES | ₹25,811.5 Cr | 0.6% | 6.6% | 56.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,794.0 Cr | 1.7% | -2.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,956.0 Cr | 2% | -2.2% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,820.0 Cr | -1.8% | -0.1% | 36.7% | Stock Analytics | |
| CIPLA | ₹109,370.0 Cr | -2% | -3.3% | -9.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,133.0 Cr | -0.6% | -3.8% | -6.9% | Stock Analytics | |
SAI LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAI LIFE SCIENCES | 0.6% |
6.6% |
56.5% |
| SENSEX | 1.7% |
2.1% |
-6% |
You may also like the below Video Courses
